Antimicrobial Agents Practice Questions

Q: What is the chemoprophylaxis dose of chloroquine?

300 mg once weekly. **Explanation:** Chloroquine is a 4-aminoquinoline used for the prophylaxis and treatment of malaria in areas where the parasite remains sensitive. **1. Why Option D is correct:** The standard chemoprophylaxis dose for an adult is **300 mg (base) once weekly**. This dose is equivalent to 500 mg of chloroquine phosphate. Prophylaxis should ideally start 1–2 weeks before entering an endemic area, continue weekly during the stay, and persist for 4 weeks after leaving the area. This regimen maintains a steady-state therapeutic concentration in the blood to eliminate erythrocytic forms of *Plasmodium* (suppressive prophylaxis). **2. Why other options are incorrect:** * **Option A (300 mg twice weekly):** This is not a standard prophylactic regimen and would increase the risk of cumulative toxicity, such as retinal damage. * **Option B & C (600 mg weekly):** 600 mg (base) is the **loading dose** used in the treatment of an acute attack of malaria, not for prophylaxis. Using this dose weekly would lead to significant gastrointestinal and neurological side effects. **Clinical Pearls for NEET-PG:** * **Mechanism:** It inhibits the heme polymerase enzyme, leading to the accumulation of toxic heme within the parasite. * **Safe in Pregnancy:** Chloroquine is the drug of choice for malaria prophylaxis and treatment in pregnant women (in sensitive areas). * **Adverse Effects:** Long-term use requires monitoring for **bull’s eye retinopathy** (irreversible) and cardiomyopathy. * **Contraindications:** Avoid in patients with G6PD deficiency (risk of hemolysis), psoriasis (may exacerbate skin lesions), and epilepsy.

Q: Which of the following antimicrobial agents is least nephrotoxic?

Doxycycline. ### Explanation The correct answer is **Doxycycline (Option D)**. **1. Why Doxycycline is the Correct Answer:** Doxycycline is a tetracycline derivative that is unique because it is primarily excreted through the **biliary tract (feces)** rather than the kidneys. It undergoes significant enterohepatic circulation and is eliminated as an inactive chelate in the stool [2]. Because it does not accumulate in the blood even in patients with renal failure, it is considered the **safest tetracycline for patients with renal impairment** and is virtually non-nephrotoxic. **2. Why the Other Options are Incorrect:** * **Gentamicin (Option B):** Aminoglycosides are notorious for causing **Acute Tubular Necrosis (ATN)**. Gentamicin is highly nephrotoxic because it accumulates in the proximal convoluted tubule cells [1]. * **Streptomycin (Option A):** While Streptomycin is generally considered the least nephrotoxic among the aminoglycosides, it still carries a significant risk of renal damage compared to Doxycycline [1]. * **Polymyxin B (Option C):** Polymyxins act like detergents on cell membranes. They are highly nephrotoxic and neurotoxic; their systemic use is often limited by their tendency to cause severe renal tubular damage. **3. High-Yield Clinical Pearls for NEET-PG:** * **"D" for Doxycycline = "D" for Does not** accumulate in the kidney. * **Tetracycline to avoid in renal failure:** All tetracyclines (especially Tetracycline and Oxytetracycline) are contraindicated in renal failure due to their anti-anabolic effect, which increases BUN (Azotemia). **Doxycycline is the sole exception.** [2] * **Drug of Choice:** Doxycycline is the drug of choice for Chlamydia, Rickettsial infections (Rocky Mountain Spotted Fever), and Brucellosis (with Rifampicin) [2]. * **Fanconi Syndrome:** Expired tetracyclines cause a form of nephrotoxicity known as Fanconi Syndrome (proximal renal tubular acidosis).

Q: Which of the following agents is active against atypical mycobacteria?

All of the above. **Explanation:** Atypical mycobacteria, also known as **Non-Tuberculous Mycobacteria (NTM)** (e.g., *Mycobacterium avium complex* [MAC], *M. kansasii*, *M. marinum*), differ from *M. tuberculosis* in their susceptibility patterns. They are often resistant to standard first-line anti-tubercular drugs (HRZE) but respond to a combination of macrolides, rifamycins, and fluoroquinolones. * **Clarithromycin (Option A):** This is the **drug of choice** for both the treatment and prophylaxis of *Mycobacterium avium complex* (MAC). It inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. * **Rifabutin (Option B):** A derivative of Rifampin, it is significantly more active against atypical mycobacteria. It is frequently used for MAC prophylaxis in HIV patients with low CD4 counts because it has a longer half-life and fewer cytochrome P450 drug interactions than rifampin. * **Ciprofloxacin (Option C):** Fluoroquinolones exhibit potent bactericidal activity against various NTMs, particularly *M. kansasii* and *M. fortuitum*, by inhibiting DNA gyrase. Since all three classes of drugs listed are clinically utilized in the management of atypical mycobacterial infections, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **MAC Prophylaxis:** Started in HIV patients when **CD4 count < 50 cells/mm³**. Azithromycin or Clarithromycin are preferred. * **Buruli Ulcer:** Caused by *M. ulcerans*; treated with Rifampicin + Streptomycin/Clarithromycin. * **Fish Tank Granuloma:** Caused by *M. marinum*; often treated with Clarithromycin or Minocycline. * **Rapid Growers:** *M. fortuitum, M. chelonae, and M. abscessus* are often sensitive to Amikacin and Clarithromycin.

Q: All of the following are common adverse effects of HAART therapy except?

Optic neuritis. Highly Active Antiretroviral Therapy (HAART) is associated with a specific cluster of metabolic and mitochondrial toxicities. **Explanation of the Correct Answer:** **Optic neuritis (Option C)** is **not** a common adverse effect of HAART. While it is a classic side effect of **Ethambutol** (used in TB) or certain infections like CMV in HIV patients, it is not typically caused by antiretroviral drugs. **Explanation of Incorrect Options:** * **Steatosis (Option A):** Nucleoside Reverse Transcriptase Inhibitors (NRTIs), especially Zidovudine, Stavudine, and Didanosine, cause **mitochondrial toxicity** by inhibiting DNA polymerase-gamma. This leads to lactic acidosis and hepatic steatosis (fatty liver). * **Lipodystrophy (Option B):** This is a hallmark side effect of HAART, characterized by "Cushingoid" fat redistribution (buffalo hump, abdominal obesity) and peripheral fat wasting. It is most commonly associated with **Protease Inhibitors (PIs)** and certain NRTIs (Stavudine). * **Increased Cholesterol (Option D):** Dyslipidemia (elevated triglycerides and LDL) is a very common metabolic complication of **Protease Inhibitors** (e.g., Ritonavir, Lopinavir), which interfere with lipid metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for NRTI toxicity:** "L-M-N" (Lactic acidosis, Mitochondrial toxicity, Nucleoside analogs). * **Zidovudine:** Most common side effect is **Anemia/Bone marrow suppression**. * **Abacavir:** Associated with **Hypersensitivity reactions** (linked to HLA-B*5701). * **Nevirapine:** Known for causing **Stevens-Johnson Syndrome (SJS)** and hepatotoxicity. * **Indinavir:** Associated with **Nephrolithiasis** (kidney stones). * **Tenofovir:** Can cause **Fanconi syndrome** (renal tubular acidosis).

Q: Reactivation of Varicella-Zoster Virus (VZV) is known to occur in persons receiving immunosuppressive therapy. Which of the following is the best antiviral for treating this infection?

Valacyclovir. **Explanation:** The question describes **Herpes Zoster (Shingles)**, which is the reactivation of the latent Varicella-Zoster Virus (VZV) within the sensory ganglia. In immunocompromised patients, prompt antiviral therapy is crucial to prevent cutaneous dissemination and visceral complications. **Why Valacyclovir is the Correct Choice:** Valacyclovir is the prodrug of Acyclovir. It is the preferred treatment for VZV reactivation because it has **superior oral bioavailability** compared to Acyclovir, leading to higher serum concentrations and less frequent dosing (TID vs. 5 times/day). It acts by inhibiting viral DNA polymerase after being phosphorylated by viral thymidine kinase. **Analysis of Incorrect Options:** * **Amantadine:** An M2 ion channel blocker formerly used for Influenza A. It has no activity against DNA viruses like VZV. * **Boceprevir:** A protease inhibitor used specifically in the treatment of Chronic Hepatitis C (HCV) genotype 1. * **Ribavirin:** A guanosine analogue used primarily for RSV (aerosolized) and Chronic Hepatitis C (in combination with interferon). It is not indicated for VZV. **High-Yield Clinical Pearls for NEET-PG:** * **Tzanck Smear:** A rapid bedside test showing **Multinucleated Giant Cells** with Cowdry Type A intranuclear inclusions (seen in both HSV and VZV). * **Post-Herpetic Neuralgia (PHN):** The most common complication of Shingles; early treatment with Valacyclovir reduces its duration. * **Ramsay Hunt Syndrome:** Reactivation of VZV in the geniculate ganglion, presenting with facial palsy and vesicles in the external auditory canal. * **Drug of Choice for Disseminated VZV:** Intravenous (IV) Acyclovir is preferred over oral routes in severe or disseminated cases.

Q: Which of the following drugs is not required in the treatment of cysticercosis?

Ketoconazole. **Explanation:** The management of **Cysticercosis** (infection by the larval stage of *Taenia solium*) involves a combination of antiparasitic drugs, corticosteroids, and anticonvulsants. **Why Ketoconazole is the correct answer:** **Ketoconazole** is an antifungal agent that inhibits ergosterol synthesis. It has no activity against helminths or the larvae of *Taenia solium*. Furthermore, Ketoconazole is a potent **CYP450 inhibitor**. This is clinically significant because it can interfere with the metabolism of other drugs, but it plays no therapeutic role in treating cysticercosis. **Analysis of other options:** * **Albendazole (Option A):** This is the **drug of choice** for neurocysticercosis. It is a cysticidal agent that crosses the blood-brain barrier effectively to kill the larvae. * **Praziquantel (Option B):** Another potent anthelmintic used as an alternative or adjunct to Albendazole. It increases the permeability of the parasite cell membrane to calcium, leading to paralysis and death of the cyst. * **Levetiracetam (Option C):** Seizures are the most common clinical presentation of neurocysticercosis. **Antiepileptic drugs (AEDs)** like Levetiracetam, Carbamazepine, or Phenytoin are essential to manage and prevent seizures during the inflammatory phase of treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Steroids First:** Always administer corticosteroids (e.g., Dexamethasone) *before* starting antiparasitic drugs to prevent a severe inflammatory response (Herxheimer-like reaction) caused by dying cysts in the brain. * **Drug Interaction:** Phenytoin and Carbamazepine (enzyme inducers) can **decrease** the plasma levels of Praziquantel and Albendazole. * **Ocular Cysticercosis:** Antiparasitic drugs are generally **contraindicated** in intraocular cysticercosis as the resulting inflammation can cause permanent blindness; surgical removal is preferred.

Q: Which of the following statement is not true regarding dapsone?

Poor oral absorption. **Explanation:** Dapsone (Diaminodiphenyl sulfone) is the cornerstone of multidrug therapy (MDT) for leprosy. The statement "Poor oral absorption" is **incorrect** because Dapsone is actually **well-absorbed** from the gastrointestinal tract, with nearly 100% bioavailability. It is widely distributed in the body and undergoes enterohepatic circulation. **Analysis of other options:** * **Option A (Mechanism of Action):** Dapsone is a structural analog of PABA. It acts by competitively inhibiting the enzyme **dihydropteroate synthase**, thereby blocking folic acid synthesis in *M. leprae*. This is the same mechanism as sulfonamides. * **Option C (DDS Syndrome):** Also known as "Sulfone Syndrome," this is a severe hypersensitivity reaction occurring 4–6 weeks after starting therapy. It is characterized by fever, malaise, exfoliative dermatitis, jaundice, and lymphadenopathy. * **Option D (Hemolysis):** Dapsone causes oxidative stress. It can lead to dose-related hemolysis, especially in patients with **G6PD deficiency**. It is also frequently associated with methemoglobinemia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Dapsone is used for Leprosy, Dermatitis Herpetiformis, and *Pneumocystis jirovecii* prophylaxis. * **Metabolism:** It is metabolized via **acetylation** (similar to Isoniazid and Hydralazine). * **Side Effects:** Remember the triad of **Hemolysis, Methemoglobinemia, and Sulfone Syndrome.** * **Lepra Reactions:** Dapsone is continued during Type 1 and Type 2 lepra reactions.

Q: Pseudojaundice is an adverse effect of which of the following drugs?

Rifabutin. **Explanation:** **Pseudojaundice** refers to a yellowish-orange discoloration of the skin and mucous membranes without an elevation in serum bilirubin levels. Unlike true jaundice, the sclera is typically spared. **Correct Option: B. Rifabutin** Rifabutin, a rifamycin derivative used primarily in the treatment of *Mycobacterium avium* complex (MAC) and tuberculosis, is known to cause a harmless, reversible yellowish-orange discoloration of the skin, urine, and secretions. This phenomenon is termed **pseudojaundice**. It occurs due to the drug’s inherent pigment and its metabolites. It is important to distinguish this from drug-induced hepatitis, where scleral icterus and elevated liver enzymes would be present. **Incorrect Options:** * **A. Phenytoin:** Known for causing gingival hyperplasia, hirsutism, and Stevens-Johnson Syndrome (SJS), but not pseudojaundice. * **C. Omeprazole:** A Proton Pump Inhibitor (PPI) commonly associated with hypomagnesemia and B12 deficiency; it does not cause skin discoloration. * **D. Chlorpromazine:** This antipsychotic can cause a **blue-gray skin pigmentation** in sun-exposed areas and corneal/lens opacities, but not yellowing. **High-Yield Clinical Pearls for NEET-PG:** * **Other causes of Pseudojaundice:** Excessive intake of Beta-carotene (Carotenemia) and drugs like **Quinacrine**. * **Rifampin vs. Rifabutin:** While both discolor secretions (orange urine), Rifabutin is more specifically linked to the clinical term "pseudojaundice" and **uveitis** (a dose-dependent side effect). * **Scleral Sparing:** The hallmark of pseudojaundice is that the **sclera remains white**, whereas in true jaundice (icterus), the sclera is the first site to turn yellow due to high elastin content's affinity for bilirubin.

Q: Which antitubercular drug causes hepatic adaptation?

Isoniazid. ### Explanation **Correct Option: A (Isoniazid)** Hepatic adaptation refers to a transient, asymptomatic rise in serum transaminases (AST/ALT) that occurs in approximately 10–20% of patients starting **Isoniazid (INH)**. This is a self-limiting phenomenon where the liver enzymes increase (usually <3 times the upper limit of normal) and then return to baseline even while the drug is continued. It represents a physiological adjustment of the liver to the drug metabolites rather than true hepatotoxicity. True INH-induced hepatitis is much rarer (1%) and requires drug discontinuation. **Analysis of Incorrect Options:** * **B. Rifampicin:** While Rifampicin is a potent inducer of microsomal enzymes and can cause dose-dependent cholestatic jaundice, it does not typically cause the specific "adaptation" phenomenon associated with INH. When used with INH, it increases the risk of hepatotoxicity by inducing enzymes that produce toxic metabolites. * **C. Pyrazinamide:** This is the **most hepatotoxic** drug among the first-line ATT. It causes dose-related hepatotoxicity and does not show a benign "adaptation" phase; any significant rise in enzymes usually necessitates immediate cessation. * **D. Ethambutol:** This drug is primarily excreted by the kidneys and is **not hepatotoxic**. Its primary side effect is optic neuritis (retrobulbar neuritis). **NEET-PG High-Yield Pearls:** * **Most Hepatotoxic ATT:** Pyrazinamide > Isoniazid > Rifampicin. * **Least Hepatotoxic/Safe in Liver Disease:** Ethambutol and Streptomycin. * **INH Toxicity:** Associated with peripheral neuropathy (prevented by Pyridoxine/Vit B6) and Sideroblastic anemia. * **Clinical Rule:** Stop ATT if Transaminases are >3 times normal with symptoms (nausea, jaundice) or >5 times normal if asymptomatic.

Question 1

Which of the following drugs requires no or minor adjustment in renal failure?

Accepted Answer

Vancomycin

Answer

Doxycycline

Answer

Chloramphenicol

Answer

Clindamycin

Question 2

What is the chemoprophylaxis dose of chloroquine?

Accepted Answer

300 mg once weekly

Answer

300 mg twice weekly

Answer

600 mg once weekly

Answer

600 mg weekly

Question 3

Which of the following antimicrobial agents is least nephrotoxic?

Accepted Answer

Doxycycline

Answer

Streptomycin

Answer

Gentamicin

Answer

Polymyxin B

Question 4

Which of the following agents is active against atypical mycobacteria?

Accepted Answer

All of the above

Answer

Clarithromycin

Answer

Rifabutin

Answer

Ciprofloxacin

Question 5

All of the following are common adverse effects of HAART therapy except?

Accepted Answer

Optic neuritis

Answer

Steatosis

Answer

Lipodystrophy

Answer

Increased cholesterol

Question 6

Reactivation of Varicella-Zoster Virus (VZV) is known to occur in persons receiving immunosuppressive therapy. Which of the following is the best antiviral for treating this infection?

Accepted Answer

Valacyclovir

Answer

Amantadine

Answer

Boceprevir

Answer

Ribavirin

Question 7

Which of the following drugs is not required in the treatment of cysticercosis?

Accepted Answer

Ketoconazole

Answer

Albendazole

Answer

Praziquantel

Answer

Levetiracetam

Question 8

Which of the following statement is not true regarding dapsone?

Accepted Answer

Poor oral absorption

Answer

It acts by inhibiting folic acid synthesis

Answer

It can cause DDS syndrome

Answer

Can cause hemolysis

Question 9

Pseudojaundice is an adverse effect of which of the following drugs?

Accepted Answer

Rifabutin

Answer

Phenytoin

Answer

Omeprazole

Answer

Chlorpromazine

Question 10

Which antitubercular drug causes hepatic adaptation?

Accepted Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Answer

Ethambutol

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?